Makary’s Compassionate Use Comments, Later Clarified, Still May Startle Industry

 
• By Derrick Gingery
  
Compassionate use requests traditionally are reviewed by career FDA staff. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from United States